The SyncroPatch 384 is installed at the FDA for cardiac safety pharmacology studies

Munich, Germany, March 8^th 2022: Nanion is pleased to announce that a SyncroPatch 384 instrument has been installed at the Food and Drug Administration (FDA) at their Silver Spring site in Maryland. The SyncroPatch 384 will be used for high throughput automated patch clamp experiments for cardiac safety experiments.

You can find and download the Press Release in the section below.